Гепатомегалия – один из самых частых симптомов у детей. Увеличение печени может отмечаться при любом инфекционном и неинфекционном воспалительном заболевании, быть ранним клиническим признаком острого лейкоза, системного заболевания соединительной ткани, новообразований печени, врожденных нарушений метаболизма, недостаточности кровообращения и дыхательной недостаточности, гельминтозов, токсического действия медикаментов, аномалий развития билиарного тракта. В подавляющем большинстве случаев выявить причину гепатомегалии помогают простейшие методы исследования, которые давно стали рутинными в повседневной работе врача-педиатра: ультразвуковое исследование органов брюшной полости, общий и биохимический анализ крови. В статье рассматривается редкий случай инфантильной мультифокальной гемангиомы печени у девочки первого полугодия жизни, потребовавший длительного диагностического поиска, участия специалистов различного профиля.
Hepatomegaly is one of the most common symptoms in children. Liver enlargement can be observed in any infectious and non-infectious inflammatory disease, be an early clinical sign of acute leukemia, systemic connective tissue disease, liver neoplasms, congenital metabolic disorders, circulatory and respiratory failure, helminthiases, toxic effects of drugs, abnormalities of the biliary tract, etc. In the vast majority of cases, the simple examination methods that have long become routine in pediatrician practice help to identify the cause of hepatomegaly: abdominal ultrasound, complete blood count, and blood chemistry. The article presents a rare case of infantile multifocal hepatic hemangioma in a girl in early infancy, which required a long diagnostic search involving various specialists.
1. Тур А.Ф. Пропедевтика детских болезней. М.: МЕДГИЗ, 1955. 363 с. [Tur AF. Propedevtika detskikh boleznei. Moscow: MEDGIZ, 1955. 363 p. (in Russian)].
2. Камышников В.С. Норма в лабораторной медицине: справочник. М.: МЕДпресс-информ, 2014. 334 с. [Kamyshnikov VS. Norma v laboratornoi meditsine: spravochnik. Moscow: MEDpress-inform, 2014. 334 p. (in Russian)].
3. Пыков М.И. Детская ультразвуковая диагностика. Учебник в 2 т. Т. 1. Гастроэнтерология. М.: Видар-М, 2014. 256 с. [Pykov MI. Detskaia ultrazvukovaia diagnostika. In 2 vol. Vol. 1. Gastroenterologiia. Moscow: Vidar-M, 2014. 256 p. (in Russian)].
4. Kim S, Kim M-J, Lee M-J, et al. Ultrasonographic findings of type IIIa biliary atresia. Ultrasonography. 2014;33(4):267-74. DOI:10.14366/usg.14016
5. Lee S, Cheon J-E, Choi Y, et al. Ultrasonographic Diagnosis of Biliary Atresia Based on a Decision-Making Tree Model. Korean J Radiol.
2015;16(6):1364-72. DOI:10.3348/kjr.2015.16.6.1364
6. Шерлок Ш., Дули Дж. Заболевания печени и желчных путей. Пер с англ. М.: ГЭОТАР, 1999. 860 с. [Sherlok Sh, Duli Dzh. Zabolevaniia pecheni i zhelchnykh putei. Moscow: GEOTAR, 1999. 860 p. (in Russian)].
7. Shabbir Z, Javaid A, Din IU. Infantile Hepatic Hemangioma. J Pak Med Assoc. 2018;68(12):1846-7.
8. Kanada KN, Merin MR, Munden A, et al. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr. 2012;161:240-5. DOI:10.1016/j.jpeds.2012.02.052
9. Подкаменев А.В., Сырцова А.Р., Ти Р.А., и др. Гигантские гемангиомы печени у новорожденных: краткий литературный обзор с описанием двух клинических случаев. Педиатр. 2020;11(5):57-65 [Podkamenev AV, Syrtsova AR, Ti RA, et al. Gigantskie gemangiomy pecheni u novorozhdennykh: kratkii literaturnyi obzor s opisaniem dvukh klinicheskikh sluchaev. Pediatr. 2020;11(5):57-65 (in Russian)]. DOI:10.17816/PED11557-65
10. Chen XD, Ma G, Chen H, et al. Maternal and perinatal risk factors for infantile hemangioma: A case-control study. Pediatr Dermatol. 2013;30:457-61. DOI:10.1111/pde.12042
11. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. New Engl J Med. 1999;341:173-81. DOI:10.1056/NEJM199907153410307
12. Ji Y, Chen S, Xiang B, et al. Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study. Sci Rep. 2016;6:31744. DOI:10.1038/srep31744
13. Ozdemir LC, Kar YD, Sohret NC, et al. Beta blocker and steroid therapy in the treatment of infantile hepatic hemangioendothelioma. Drug Discoveries & Therapeutics.
2017;11(3):161-4. DOI:10.5582/ddt.2017.01025
14. Петрушин А.В., Мыльников А.А., Гарбузов Р.В., и др. Алгоритм диагностики и выбор методов лечения различных форм гемангиом печени у детей. Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2017;16(1):22-7 [Petrushin AV, Mylnikov AA, Garbuzov RV, et al. Diagnostic procedure and choice of treatment of various forms of liver hemangiomas in children. Pediatric Hematology/Oncology and Immunopathology. 2017;16(1):22-7 (in Russian)]. DOI:10.24287/1726-1708-2017-16-1-22-27
15. Campbell V, Beckett R, Adid N, Hoey S. Resolution of Consumptive Hypothyroidism Secondary to Infantile Hepatic Hemangiomatosis with a Combination of Propranolol and Levothyroxine. J Clin Res Pediatr Endocrinol. 2018;10(3):294-8. DOI:10.4274/jcrpe.4865
16. Zhang Z, Chen H-J, Yang WJ, et al. Infantile hepatic hemangioendothelioma: A clinicopathologic study in a Chinese population. World J Gastroenterol.
2010;16(36):4549-57. DOI:10.3748/wjg.v16.i36.4549
17. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Eng J Med.
2000;343:185-9. DOI:10.1056/NEJM200007203430305
18. Huang SA, Fish SA, Dorfman DM, et al. A 21-year-old woman with consumptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase. J Clin Endocrinol Metab. 2002;87:4457-61. DOI:10.1210/jc.2002-020627
19. Yeh I, Bruckner A, Sanchez R, et al. Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy. Pediatr Dermatol. 2011;28:267-75. DOI:10.1111/j.1525-1470.2011.01421.x
20. Fisher DA. Clinical review 19: Management of congenital hypothyroidism. J Clin Endocr Metab. 1991;72:523-9. DOI:10.1210/jcem-72-3-523
21. Bessho K, Etani Y, Ichimori H, et al. Increased type 3 iodothyronine deiodinase activity in a regrown hepatic hemangioma with consumptive hypothyroidism. Eur J Pediatr. 2010;169:215-21. DOI:10.1007/s00431-009-1009-x
22. Cho YH, Taplin C, Mansour A, et al. Case report: consumptive hypothyroidism consequent to multiple infantile hepatic hemangiomas. Curr Opin in Pediatr.
2008;20:213-5. DOI:10.1097/MOP.0b013e3282f409c3
23. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649-51. DOI:10.1056/NEJMc0708819
24. Torres E, Rosa J, Leaute-Labreze C, Soares-de-Almeida L. Multifocal infantile haemangioma: a diagnostic challenge. BMJ Case Rep. 2016:bcr2016214827.
DOI:10.1136/bcr-2016-214827
25. Tsai M-C, Liu H-C, Yeung C-Y. Efficacy of infantile hepatic hemangioma with propranolol treatment. A case report. Medicine. 2019;98(4):e14078. DOI:10.1097/MD.0000000000014078
________________________________________________
1. Тур А.Ф. Пропедевтика детских болезней. М.: МЕДГИЗ, 1955. 363 с. [Tur AF. Propedevtika detskikh boleznei. Moscow: MEDGIZ, 1955. 363 p. (in Russian)].
2. Kamyshnikov VS. Norma v laboratornoi meditsine: spravochnik. Moscow: MEDpress-inform, 2014. 334 p. (in Russian).
3. Pykov MI. Detskaia ultrazvukovaia diagnostika. In 2 vol. Vol. 1. Gastroenterologiia. Moscow: Vidar-M, 2014. 256 p. (in Russian).
4. Kim S, Kim M-J, Lee M-J, et al. Ultrasonographic findings of type IIIa biliary atresia. Ultrasonography. 2014;33(4):267-74. DOI:10.14366/usg.14016
5. Lee S, Cheon J-E, Choi Y, et al. Ultrasonographic Diagnosis of Biliary Atresia Based on a Decision-Making Tree Model. Korean J Radiol.
2015;16(6):1364-72. DOI:10.3348/kjr.2015.16.6.1364
6. Sherlok Sh, Duli Dzh. Zabolevaniia pecheni i zhelchnykh putei. Moscow: GEOTAR, 1999. 860 p. (in Russian).
7. Shabbir Z, Javaid A, Din IU. Infantile Hepatic Hemangioma. J Pak Med Assoc. 2018;68(12):1846-7.
8. Kanada KN, Merin MR, Munden A, et al. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr. 2012;161:240-5. DOI:10.1016/j.jpeds.2012.02.052
9. Podkamenev AV, Syrtsova AR, Ti RA, et al. Gigantskie gemangiomy pecheni u novorozhdennykh: kratkii literaturnyi obzor s opisaniem dvukh klinicheskikh sluchaev. Pediatr. 2020;11(5):57-65 (in Russian). DOI:10.17816/PED11557-65
10. Chen XD, Ma G, Chen H, et al. Maternal and perinatal risk factors for infantile hemangioma: A case-control study. Pediatr Dermatol. 2013;30:457-61. DOI:10.1111/pde.12042
11. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. New Engl J Med. 1999;341:173-81. DOI:10.1056/NEJM199907153410307
12. Ji Y, Chen S, Xiang B, et al. Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study. Sci Rep. 2016;6:31744. DOI:10.1038/srep31744
13. Ozdemir LC, Kar YD, Sohret NC, et al. Beta blocker and steroid therapy in the treatment of infantile hepatic hemangioendothelioma. Drug Discoveries & Therapeutics.
2017;11(3):161-4. DOI:10.5582/ddt.2017.01025
14. Petrushin AV, Mylnikov AA, Garbuzov RV, et al. Diagnostic procedure and choice of treatment of various forms of liver hemangiomas in children. Pediatric Hematology/Oncology and Immunopathology. 2017;16(1):22-7 (in Russian). DOI:10.24287/1726-1708-2017-16-1-22-27
15. Campbell V, Beckett R, Adid N, Hoey S. Resolution of Consumptive Hypothyroidism Secondary to Infantile Hepatic Hemangiomatosis with a Combination of Propranolol and Levothyroxine. J Clin Res Pediatr Endocrinol. 2018;10(3):294-8. DOI:10.4274/jcrpe.4865
16. Zhang Z, Chen H-J, Yang WJ, et al. Infantile hepatic hemangioendothelioma: A clinicopathologic study in a Chinese population. World J Gastroenterol.
2010;16(36):4549-57. DOI:10.3748/wjg.v16.i36.4549
17. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Eng J Med.
2000;343:185-9. DOI:10.1056/NEJM200007203430305
18. Huang SA, Fish SA, Dorfman DM, et al. A 21-year-old woman with consumptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase. J Clin Endocrinol Metab. 2002;87:4457-61. DOI:10.1210/jc.2002-020627
19. Yeh I, Bruckner A, Sanchez R, et al. Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy. Pediatr Dermatol. 2011;28:267-75. DOI:10.1111/j.1525-1470.2011.01421.x
20. Fisher DA. Clinical review 19: Management of congenital hypothyroidism. J Clin Endocr Metab. 1991;72:523-9. DOI:10.1210/jcem-72-3-523
21. Bessho K, Etani Y, Ichimori H, et al. Increased type 3 iodothyronine deiodinase activity in a regrown hepatic hemangioma with consumptive hypothyroidism. Eur J Pediatr. 2010;169:215-21. DOI:10.1007/s00431-009-1009-x
22. Cho YH, Taplin C, Mansour A, et al. Case report: consumptive hypothyroidism consequent to multiple infantile hepatic hemangiomas. Curr Opin in Pediatr.
2008;20:213-5. DOI:10.1097/MOP.0b013e3282f409c3
23. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649-51. DOI:10.1056/NEJMc0708819
24. Torres E, Rosa J, Leaute-Labreze C, Soares-de-Almeida L. Multifocal infantile haemangioma: a diagnostic challenge. BMJ Case Rep. 2016:bcr2016214827.
DOI:10.1136/bcr-2016-214827
25. Tsai M-C, Liu H-C, Yeung C-Y. Efficacy of infantile hepatic hemangioma with propranolol treatment. A case report. Medicine. 2019;98(4):e14078. DOI:10.1097/MD.0000000000014078
1ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России, Москва, Россия; 2ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России, Москва, Россия; 3ГБУЗ «ДГКБ им. З.А. Башляевой» Департамента здравоохранения г. Москвы, Москва, Россия; 4БУЗ ВО «Воронежская областная детская клиническая больница №1», Воронеж, Россия
*alex.goriaynowa@yandex.ru
________________________________________________
Aleksandra N. Goryainova*1, Ismail M. Osmanov2,3, Irina D. Maykova3, Irina G. Kolomina3, Tatiana R. Lavrova3, Larisa N. Lukankina4, Sergei S. Bukin3, Ludmila V. Goncharova3, Olga I. Elfimova3, Natalia V. Koroid3, Natalia E. Kuzina3, Iuliia A. Riapolova3
1Russian Medical Academy of Continuous Professional Education, Moscow, Russia; 2Pirogov Russian National Research Medical University, Moscow, Russia; 3Bashlyaeva Children’s City Clinical Hospital, Moscow, Russia; 4Voronezh Regional Children’s Clinical Hospital No. 1, Voronezh, Russia
*alex.goriaynowa@yandex.ru